Beta
ManageSearchChatDiscover
323618

Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats

Article

Last updated: 03 Jan 2025

OverviewSimilar Items

Subjects

-

Tags

-

DOI

10.21608/fumj.2023.323618

Authors

First Name

Hanan

Last Name

Shamardl

MiddleName

-

Affiliation

Medical Pharmacology department - Faculty of Medicine , Fayoum University

Email

-

City

-

Orcid

-

First Name

Sawsan

Last Name

Sadek

MiddleName

-

Affiliation

Medical Pharmacology department - Faculty of Medicine , Fayoum University

Email

sas01@fayoum.edu.eg

City

-

Orcid

-

First Name

Amany

Last Name

Ahmed

MiddleName

-

Affiliation

Medical Pharmacology department - Faculty of Medicine, Fayoum University

Email

ana03@fayoum.edu.eg

City

-

Orcid

-

Volume

12

Article Issue

2

Related Issue

44121

Issue Date

2023-10-01

Receive Date

2023-09-19

Publish Date

2023-10-01

Page Start

84

Page End

94

Print ISSN

2536-9474

Online ISSN

2536-9482

Article File

FUMJ_Volume 12_Issue 2_Pages 84-94.pdf

PDF . 593.0kB

Link

https://fumj.journals.ekb.eg/article_323618.html

Detail API

https://fumj.journals.ekb.eg/service?article_code=323618

Order

323,618

Type

Review Articles

Type Code

480

Publication Type

Journal

Publication Title

Fayoum University Medical Journal

Publication Link

https://fumj.journals.ekb.eg/

MainTitle

Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats

Details

Type

Article

Created At

23 Dec 2024